Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 304
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00749450 | Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer | ||
| NCT07391215 | 5G-PEARL: Paxalisib in Malignant Brain Tumours | ||
| NCT02724163 | International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia | ||
| NCT05574738 | A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer | ||
| NCT00755885 | Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer | ||
| NCT05361135 | 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia | ||
| NCT00758056 | Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom | ||
| NCT03004755 | The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study | ||
| NCT04523116 | Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 | ||
| NCT03466034 | The Role of Hypoxia as a Selective Pressure for TP53 Mutations | ||
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours | ||
| NCT03916510 | Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer | ||
| NCT01836692 | Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study | ||
| NCT06988475 | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations | ||
| NCT03410030 | Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) | ||
| NCT00664781 | Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer | ||
| NCT02695966 | EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer | ||
| NCT02308072 | Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer | ||
| NCT01810757 | Study of Weekly Radiotherapy for Bladder Cancer | ||
| NCT00562068 | Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma | ||
| NCT02758587 | Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) | ||
| NCT01584258 | Prostate Advances in Comparative Evidence | ||
| NCT02043899 | A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma | ||
| NCT02583542 | A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | ||
| NCT04063566 | ReIMAGINE Prostate Cancer Screening | ||
| NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | ||
| NCT01843829 | A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer | ||
| NCT02874729 | Assay Development for Cancer Biomarkers | ||
| NCT02960620 | Therasphere for Unresectable Primary or Secondary Liver Neoplasia | ||
| NCT00678327 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | ||
| NCT00003969 | Geldanamycin Analogue in Treating Patients With Advanced Cancer | ||
| NCT07440290 | DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. | ||
| NCT05991388 | A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma | ||
| NCT04084145 | National Unified Renal Translation Research Enterprise - Chronic Kidney Disease | ||
| NCT00967954 | Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | ||
| NCT02768337 | Cambridge Brain Mets Trial 1 | ||
| NCT01140737 | A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas | ||
| NCT02423603 | PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer | ||
| NCT07002320 | Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer | ||
| NCT01902667 | Preoperative Imaging in Retroperitoneal Sarcoma | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT05768178 | DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. | ||
| NCT01233492 | Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme | ||
| NCT02308527 | Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children | ||
| NCT00112931 | Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma | ||
| NCT00002460 | Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer | ||
| NCT02051868 | International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel | ||
| NCT04842799 | Digital Delivery of Information About Genetic Testing for Breast Cancer | ||
| NCT07033598 | Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia | ||
| NCT01977638 | Phase 1 Trial of CXD101 in Patients With Advanced Cancer |
